Overview
Orbit Neuro develops a non-invasive brain-computer interface that decodes emotional and cognitive states from neural signals to help devices respond to human feelings. Its wearable BCI uses neural sensors, hardware, software, and machine-learning models to provide real-time, multi-modal data with high imaging resolution similar to fMRI, all while remaining untethered. The company distinguishes itself with a full-stack approach focused on emotion interfacing and a high-resolution, portable imaging capability to build emotion-based foundation models and NeuroAI. Its goal is to place human wellbeing at the center of technology by enabling mental health support and more emotionally aware human-computer interactions.
Work here?Claim your company
Simplify's take
What believers are saying
- Orbit posted two San Francisco engineering roles in October 2026, showing active hiring.
- The company claims development of a first consumer neurotech device within 2027.
- Backers tied to Google, Apple, Microsoft, and Hugging Face strengthen recruiting and credibility.
What critics are saying
- Orbit still lacks a public product launch or commercial customers as of November 2026.
- Only two investors are publicly recorded, and no funding round appears after July 2025.
- Clinical-study recruiting jobs in 2026 signal heavy execution risk before any consumer launch.
What makes Orbit Neuro unique
- Orbit Neuro's 2024-founded wearable BCI targets emotion decoding, not generic neurotracking.
- Its full-stack approach spans neural sensors, hardware, software, and multimodal emotion models.
- Orbit claims fMRI-comparable resolution untethered from the lab, a rare technical ambition.
Help us improve and share your feedback! Did you find this helpful?